Newsroom

Sorted by: Latest

-

UKG Turns Workforce Intelligence Into Action With New AI for the Frontline

LOWELL, Mass.--(BUSINESS WIRE)--UKG, the AI-first Workforce Operating Platform for HR, payroll, and workforce management, today announced new AI innovations that help CHROs turn workforce intelligence into action, addressing frontline challenges that can get in the way of productivity and performance — from staffing shortages and complicated HR requests to payroll errors that affect employees.HR technology has helped businesses keep track of their workforce for decades. Now, organizations need s...
-

Arch Reinsurance Group Announces Retirement of Matthew Dragonetti

NEW YORK--(BUSINESS WIRE)--Arch Reinsurance Group (Arch Re, Arch) today announced that Matthew Dragonetti, President of Arch Re Ltd., will retire effective March 2027, following a 25-year tenure with the company. “Matt has been an important part of Arch’s success over the past 25 years, and we are incredibly grateful for his leadership and contributions,” said Jerome Halgan, CEO of Arch Global Reinsurance Group. “He embodies our culture and has been relentless in helping Arch Re on its commitme...
-

Resumen: Bregal Milestone respalda a Asolvi en el desarrollo de un software de servicios de campo con tecnología de IA para sectores en los que el cumplimiento normativo es fundamental

LONDRES--(BUSINESS WIRE)--Bregal Milestone, una de las principales firmas europeas de capital riesgo de crecimiento especializada en software, ha anunciado hoy una inversión mayoritaria en Asolvi, un proveedor de software de gestión de servicios de campo (FSM) para sectores en los que el cumplimiento normativo es fundamental y con un uso intensivo de activos. Bregal Milestone adquiere su participación a Volpi Capital y Viking Growth. El director general, Nick Barnett, y el equipo directivo está...
-

Bregal Milestone unterstützt Asolvi beim Aufbau einer KI-basierten Außendienst-Software für Branchen mit hohen Compliance-Anforderungen

LONDON--(BUSINESS WIRE)--Bregal Milestone, eine führende europäische Wachstums-Private-Equity-Gesellschaft mit Spezialisierung auf Software, gab heute eine Mehrheitsbeteiligung an Asolvi bekannt, einem Anbieter von Field-Service-Management-Software (FSM) für Compliance-kritische und anlagenschwere Branchen. Bregal Milestone erwirbt seine Anteile von Volpi Capital und Viking Growth. CEO Nick Barnett und das Managementteam investieren gemeinsam mit Bregal Milestone erneut in das Unternehmen. Asol...
-

Samenvatting: Bregal Milestone steunt Asolvi om AI-first buitendienstsoftware te bouwen voor compliance-gevoelige sectoren

LONDEN--(BUSINESS WIRE)--Bregal Milestone, een vooraanstaande Europese groeikapitaalinvesteerder gespecialiseerd in software, maakte vandaag een meerderheidsinvestering bekend in Asolvi, een aanbieder van FSM-software (Field Service Management) voor compliance-gevoelige en activa-intensieve sectoren. Bregal Milestone verwerft zijn aandeel van Volpi Capital en Viking Growth. CEO Nick Barnett en het bestuursteam herinvesteren samen met Bregal Milestone. Asolvi werd in 1991 opgericht en heeft zijn...
-

Riassunto: Bregal Milestone sostiene Asolvi per creare software per i servizi sul campo basato sull'intelligenza artificiale per i settori in cui la conformità è di importanza primaria

LONDRA--(BUSINESS WIRE)--Bregal Milestone, società europea leader nel settore del private equity incentrato sulla crescita, oggi ha annunciato un investimento di maggioranza in Asolvi, un fornitore di software per la gestione dei servizi sul campo (FSM) per i settori nei quali la conformità è essenziale e caratterizzati da un elevato impiego di beni strumentali. Bregal Milestone sta acquisendo la sua quota da Volpi Capital e Viking Growth. Anche l'AD Nick Barnett e il team dirigente stanno rein...
-

Bregal Milestone soutient Asolvi dans le développement d’un logiciel de gestion des services sur le terrain axé sur l’intelligence artificielle (IA), destiné aux secteurs où la conformité est essentielle

LONDRES--(BUSINESS WIRE)--Bregal Milestone, une société européenne de capital-investissement de croissance de premier plan spécialisée dans le secteur des logiciels, a annoncé aujourd’hui avoir acquis une participation majoritaire dans Asolvi. Ce dernier, un fournisseur de logiciels de gestion des services sur le terrain (field service management, FSM) s’adresse à des secteurs à forte intensité d’actifs où la conformité constitue un élément crucial. Bregal Milestone a acquis cette participation...
-

AV Laboratories dołącza do Regenivus (Mitrone Healthcare Ltd.) podczas konferencji Aesthetic & Regenerative Medicine Conference w Dublinie

DUBLIN--(BUSINESS WIRE)--AV Laboratories, producent klinicznych rozwiązań ukierunkowanych na długowieczność skóry, łączący zaawansowane receptury naukowe z innowacjami w dziedzinie pielęgnacji skóry, ma przyjemność przekazać informację o udziale w konferencji Aesthetic & Regenerative Medicine Conference w dniach 18–19 października 2026 r. w obiekcie Croke Park (Dublin). Marka dołączy do Regenivus, wyspecjalizowanej w medycynie estetycznej marki zależnej Mitrone Healthcare Ltd., ugruntowaneg...
-

Ifrah Law Defeats Octagon Non-Compete Claims Against Client

WASHINGTON--(BUSINESS WIRE)--Ifrah Law announced that a federal court in Virginia held the non-compete and non-solicitation provisions in sports agency Octagon's employment contract unenforceable under Virginia law. The court’s ruling not only invalidated Virginia-based Octagon’s restrictive covenants, finding them overly broad and violative of Virginia law, but also found Octagon liable for violation of California law. In reaching this conclusion, the Court upheld and enforced California law d...
-

Hologic Signs Definitive Agreement to Acquire Reveal Genomics

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, a global leader in women’s health, today announced that it has signed a definitive agreement to acquire Reveal Genomics, a precision oncology company based in Barcelona, Spain, that develops advanced genomic diagnostic tests to help personalized cancer treatment, including its HER2DX test to help optimize therapy for patients with HER2-positive breast cancer. Breast cancer remains one of the most significant health challenges women face today. Revea...